496 related articles for article (PubMed ID: 17535079)
1. Comparison of the effects of policosanol and atorvastatin on lipid profile and platelet aggregation in patients with dyslipidaemia and type 2 diabetes mellitus.
Castaño G; Fernández L; Mas R; Illnait J; Mesa M; Fernández JC
Clin Drug Investig; 2003; 23(10):639-50. PubMed ID: 17535079
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the efficacy and tolerability of policosanol with atorvastatin in elderly patients with type II hypercholesterolaemia.
Castaño G; Mas R; Fernández L; Illnait J; Mesa M; Alvarez E; Lezcay M
Drugs Aging; 2003; 20(2):153-63. PubMed ID: 12534315
[TBL] [Abstract][Full Text] [Related]
3. Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients.
Castaño G; Más R; Arruzazabala ML; Noa M; Illnait J; Fernández JC; Molina V; Menéndez A
Int J Clin Pharmacol Res; 1999; 19(4):105-16. PubMed ID: 10939028
[TBL] [Abstract][Full Text] [Related]
4. Effects of addition of policosanol to omega-3 fatty acid therapy on the lipid profile of patients with type II hypercholesterolaemia.
Castaño G; Fernández L; Mas R; Illnait J; Gámez R; Mendoza S; Mesa M; Fernández J
Drugs R D; 2005; 6(4):207-19. PubMed ID: 16050054
[TBL] [Abstract][Full Text] [Related]
5. Effects of policosanol on borderline to mildly elevated serum total cholesterol levels: a prospective, double-blind, placebo-controlled, parallel-group, comparative study.
Castaño G; Más R; Fernández J; López E; Illnait J; Fernández L; Mesa M
Curr Ther Res Clin Exp; 2003 Sep; 64(8):522-37. PubMed ID: 24944402
[TBL] [Abstract][Full Text] [Related]
6. Effects of concurrent therapy with policosanol and omega-3 fatty acids on lipid profile and platelet aggregation in rabbits.
Gámez R; Máz R; Arruzazabala ML; Mendoza S; Castaño G
Drugs R D; 2005; 6(1):11-9. PubMed ID: 15806713
[TBL] [Abstract][Full Text] [Related]
7. Effects of combination treatment with policosanol and omega-3 fatty acids on platelet aggregation: A randomized, double-blind clinical study.
Castaño G; Arruzazabala ML; Fernández L; Mas R; Carbajal D; Molina V; Illnait J; Mendoza S; Gámez R; Mesa M; Fernández J
Curr Ther Res Clin Exp; 2006 May; 67(3):174-92. PubMed ID: 24678094
[TBL] [Abstract][Full Text] [Related]
8. Effects of policosanol on older patients with hypertension and type II hypercholesterolaemia.
Castaño G; Más R; Fernández JC; Fernández L; Illnait J; López E
Drugs R D; 2002; 3(3):159-72. PubMed ID: 12099160
[TBL] [Abstract][Full Text] [Related]
9. Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.
Castaño G; Menéndez R; Más R; Amor A; Fernández JL; González RL; Lezcay M; Alvarez E
Int J Clin Pharmacol Res; 2002; 22(3-4):89-99. PubMed ID: 12837046
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy, safety and tolerability of original policosanol versus other mixtures of higher aliphatic primary alcohols in patients with type II hypercholesterolemia.
Castaño G; Fernández L; Mas R; Illnait J; Fernández J; Mesa M; Alvarez E; Lezcay M
Int J Clin Pharmacol Res; 2002; 22(2):55-66. PubMed ID: 12503776
[TBL] [Abstract][Full Text] [Related]
11. Effects of policosanol and ticlopidine in patients with intermittent claudication: a double-blinded pilot comparative study.
Castaño G; Más R; Gámez R; Fernández L; Illnait J
Angiology; 2004; 55(4):361-71. PubMed ID: 15258682
[TBL] [Abstract][Full Text] [Related]
12. Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study.
Castaño G; Mas R; Fernández L; Illnait J; Gámez R; Alvarez E
Int J Clin Pharmacol Res; 2001; 21(1):43-57. PubMed ID: 11708574
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
[TBL] [Abstract][Full Text] [Related]
14. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the efficacy and tolerability of a fixed dose combination of atorvastatin 10 mg + metformin SR 500 mg in diabetic dyslipidaemia in adult Indian patients.
Balasubramanian R; Varadharajan S; Kathale A; Nagraj LM; Periyandavar I; Nayak UP; Sharma A; Bolmall C; Baliga VP
J Indian Med Assoc; 2008 Jul; 106(7):464-7. PubMed ID: 18975505
[TBL] [Abstract][Full Text] [Related]
16. Concomitant use of policosanol and beta-blockers in older patients.
Castaño G; Mas R; Gámez R; Fernández J; Illnait J; Fernández L; Mendoza S; Mesa M; Gutiérrez JA; López E
Int J Clin Pharmacol Res; 2004; 24(2-3):65-77. PubMed ID: 15689053
[TBL] [Abstract][Full Text] [Related]
17. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
Strandberg TE; Feely J; Sigurdsson EL;
Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the effects of D-003 and policosanol (5 and 10 mg/day) in patients with type II hypercholesterolemia: a randomized, double-blinded study.
Castaño G; Más R; Fernández L; Illnait J; Mendoza S; Gámez R; Fernández J; Mesa M
Drugs Exp Clin Res; 2005; 31 Suppl():31-44. PubMed ID: 16444910
[TBL] [Abstract][Full Text] [Related]
19. Hemostatic effects of atorvastatin versus simvastatin.
Kadikoylu G; Yukselen V; Yavasoglu I; Bolaman Z
Ann Pharmacother; 2003 Apr; 37(4):478-84. PubMed ID: 12659599
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]